BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 28193886)

  • 1. Improved regulatory element prediction based on tissue-specific local epigenomic signatures.
    He Y; Gorkin DU; Dickel DE; Nery JR; Castanon RG; Lee AY; Shen Y; Visel A; Pennacchio LA; Ren B; Ecker JR
    Proc Natl Acad Sci U S A; 2017 Feb; 114(9):E1633-E1640. PubMed ID: 28193886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancer prediction with histone modification marks using a hybrid neural network model.
    Lim A; Lim S; Kim S
    Methods; 2019 Aug; 166():48-56. PubMed ID: 30905748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory methods to decipher epigenetic signatures: a comparative review.
    Halabian R; Valizadeh Arshad ; Ahmadi A; Saeedi P; Azimzadeh Jamalkandi S; Alivand MR
    Cell Mol Biol Lett; 2021 Nov; 26(1):46. PubMed ID: 34763654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrapolating histone marks across developmental stages, tissues, and species: an enhancer prediction case study.
    Capra JA
    BMC Genomics; 2015 Feb; 16(1):104. PubMed ID: 25765133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accurate Promoter and Enhancer Identification in 127 ENCODE and Roadmap Epigenomics Cell Types and Tissues by GenoSTAN.
    Zacher B; Michel M; Schwalb B; Cramer P; Tresch A; Gagneur J
    PLoS One; 2017; 12(1):e0169249. PubMed ID: 28056037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics of Muscle- and Brain-Specific Expression of KLHL Family Genes.
    Ehrlich KC; Baribault C; Ehrlich M
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182325
    [No Abstract]   [Full Text] [Related]  

  • 7. Computational schemes for the prediction and annotation of enhancers from epigenomic assays.
    Whitaker JW; Nguyen TT; Zhu Y; Wildberg A; Wang W
    Methods; 2015 Jan; 72():86-94. PubMed ID: 25461775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opening up the blackbox: an interpretable deep neural network-based classifier for cell-type specific enhancer predictions.
    Kim SG; Theera-Ampornpunt N; Fang CH; Harwani M; Grama A; Chaterji S
    BMC Syst Biol; 2016 Aug; 10 Suppl 2(Suppl 2):54. PubMed ID: 27490187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RFECS: a random-forest based algorithm for enhancer identification from chromatin state.
    Rajagopal N; Xie W; Li Y; Wagner U; Wang W; Stamatoyannopoulos J; Ernst J; Kellis M; Ren B
    PLoS Comput Biol; 2013; 9(3):e1002968. PubMed ID: 23526891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MICMIC: identification of DNA methylation of distal regulatory regions with causal effects on tumorigenesis.
    Tong Y; Sun J; Wong CF; Kang Q; Ru B; Wong CN; Chan AS; Leung SY; Zhang J
    Genome Biol; 2018 Jun; 19(1):73. PubMed ID: 29871649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting enhancers in mammalian genomes using supervised hidden Markov models.
    Zehnder T; Benner P; Vingron M
    BMC Bioinformatics; 2019 Mar; 20(1):157. PubMed ID: 30917778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EAGLE: An algorithm that utilizes a small number of genomic features to predict tissue/cell type-specific enhancer-gene interactions.
    Gao T; Qian J
    PLoS Comput Biol; 2019 Oct; 15(10):e1007436. PubMed ID: 31665135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenerational inheritance: how impacts to the epigenetic and genetic information of parents affect offspring health.
    Xavier MJ; Roman SD; Aitken RJ; Nixon B
    Hum Reprod Update; 2019 Sep; 25(5):518-540. PubMed ID: 31374565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NUCLIZE for quantifying epigenome: generating histone modification data at single-nucleosome resolution using genuine nucleosome positions.
    Zheng D; Trynda J; Sun Z; Li Z
    BMC Genomics; 2019 Jul; 20(1):541. PubMed ID: 31266464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Widespread Enhancer Dememorization and Promoter Priming during Parental-to-Zygotic Transition.
    Zhang B; Wu X; Zhang W; Shen W; Sun Q; Liu K; Zhang Y; Wang Q; Li Y; Meng A; Xie W
    Mol Cell; 2018 Nov; 72(4):673-686.e6. PubMed ID: 30444999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
    Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
    Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finding combinatorial histone code by semi-supervised biclustering.
    Teng L; Tan K
    BMC Genomics; 2012 Jul; 13():301. PubMed ID: 22759587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible Regulation of Promoter and Enhancer Histone Landscape by DNA Methylation in Mouse Embryonic Stem Cells.
    King AD; Huang K; Rubbi L; Liu S; Wang CY; Wang Y; Pellegrini M; Fan G
    Cell Rep; 2016 Sep; 17(1):289-302. PubMed ID: 27681438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating diverse datasets improves developmental enhancer prediction.
    Erwin GD; Oksenberg N; Truty RM; Kostka D; Murphy KK; Ahituv N; Pollard KS; Capra JA
    PLoS Comput Biol; 2014 Jun; 10(6):e1003677. PubMed ID: 24967590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active enhancer positions can be accurately predicted from chromatin marks and collective sequence motif data.
    Podsiadło A; Wrzesień M; Paja W; Rudnicki W; Wilczyński B
    BMC Syst Biol; 2013; 7 Suppl 6(Suppl 6):S16. PubMed ID: 24565409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.